$Vir Biotechnology (VIR.US)$ GSK and Vir Biotechnology Anno...
$Vir Biotechnology (VIR.US)$
GSK and Vir Biotechnology Announce Sotrovimab (VIR-7831) Receives Emergency Use Authorization from the US FDA for Treatment of Mild-to-Moderate COVID-19 in High-Risk Adults and Pediatric Patients
https://investors.vir.bio/news-releases/news-release-details/gsk-and-vir-biotechnology-announce-sotrovimab-vir-7831-receives
GSK and Vir Biotechnology Announce Sotrovimab (VIR-7831) Receives Emergency Use Authorization from the US FDA for Treatment of Mild-to-Moderate COVID-19 in High-Risk Adults and Pediatric Patients
https://investors.vir.bio/news-releases/news-release-details/gsk-and-vir-biotechnology-announce-sotrovimab-vir-7831-receives
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
